ArticleJournal of clinical and experimental hematopathology : JCEH2026
CD83 as a novel prognostic biomarker for diffuse large B-cell lymphoma arising in immune deficiency/dysregulation among rheumatoid arthritis patients treated with methotrexate.
Keisuke Sawada et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.